GemPharmatech Co Ltd (688046)

Shanghai

Currency in CNY

17.29

-0.09(-0.52%)

Closed·08:59:59

Fair Value

Unlock Value

Day's Range

17.21

17.69

52 wk Range

10.44

20.50

688046 Income Statement

Featured here, the Income Statement (earnings report) for GemPharmatech Co Ltd, showing the company's financial performance from operating and non operating activities such as revenue, expenses and income for the last 4 periods (either quarterly or annually).

Period Ending:

2018

31/12

2019

31/12

2020

31/12

2021

31/12

2022

31/12

2023

31/12

2024

31/12

2025

31/12

Total Revenues

aa.aa

622.19

686.84

793.25

Total Revenues Growth

aa.aa

+20.45%

+10.39%

+15.49%

Cost Of Revenues

aa.aa

202.86

261.33

Gross Profit

aa.aa

419.33

425.51

793.25

Gross Profit Growth

aa.aa

+14.47%

+1.47%

+86.43%

Gross Profit Margin %

aa.aa

67.4%

61.95%

100%

Other Operating Expenses, Total

aa.aa

307.91

333.68

628.7

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	+14.92%	+8.37%	+88.42%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	96.6	87.13	-
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	208.7	242.97	-
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	2.61	3.57	628.7

Operating Income

aa.aa

111.42

91.83

164.55

Operating Income Growth

aa.aa

+13.25%

-17.58%

+79.19%

EBIT Margin %

aa.aa

17.91%

13.37%

20.74%

Net Interest Expenses

aa.aa

25.89

18.09

Net Interest Expenses Growth

aa.aa

+11.42%

-30.12%

Interest Expense, Total

aa.aa

-2.76

-4.3

Interest And Investment Income

aa.aa

28.65

22.39

Other Non Operating Expenses, Total

aa.aa

-20.83

-19.86

-0.2

EBT, Excl. Unusual Items

aa.aa

116.48

90.06

164.36

Gain (Loss) On Sale Of Assets

aa.aa

-0.02

0.01

Other Unusual Items, Total

aa.aa

42.1

26.8

EBT, Incl. Unusual Items

aa.aa

161.29

119.22

164.36

EBT, Incl. Unusual Items Growth

aa.aa

-7.14%

-26.09%

+37.87%

EBT, Incl. Unusual Items Margin

aa.aa

25.92%

17.36%

20.72%

Income Tax Expense

aa.aa

2.37

9.4

19.96

Net Income to Company

aa.aa

158.91

109.82

144.4

Minority Interest

aa.aa

Net Income

aa.aa

158.91

109.82

144.4

Net Income Growth

aa.aa

-3.49%

-30.89%

+31.49%

Net Income Margin %

aa.aa

25.54%

15.99%

18.2%

Preferred Dividend and Other Adjustments

aa.aa

Net Income to Common Excl. Extra Items

aa.aa

158.91

109.82

144.4

Basic EPS - Continuing Operations

aa.aa

0.39

0.27

0.35

Basic EPS - Continuing Operations Growth

aa.aa

-7.14%

-30.77%

+30.44%

Diluted EPS - Continuing Operations

aa.aa

0.39

0.27

0.35

Diluted EPS - Continuing Operations Growth

aa.aa

-7.14%

-30.77%

+30.44%

Basic Weighted Average Shares Outstanding

aa.aa

407.47

406.74

410

Diluted Weighted Average Shares Outstanding

aa.aa

407.47

406.74

410

Dividend Per Share

aa.aa

0.16

0.14

Dividend Per Share Growth

aa.aa

+290.24%

-12.5%

EBITDA

aa.aa

157.42

164.62

237.34

EBITDA Growth

aa.aa

+16.02%

+4.57%

+44.18%

EBITDA Margin %

aa.aa

25.3%

23.97%

29.92%

EBIT

aa.aa

111.42

91.83

164.55

* In Millions of CNY (except for per share items)

FAQ

What was GemPharmatech’s revenue at year end?

At the end of the last reported fiscal year, GemPharmatech (688046) recorded total revenue of 793,25.

How much revenue did GemPharmatech report in the most recent quarter?

In its most recent quarterly earnings report, GemPharmatech posted revenue of 217.68.

What was GemPharmatech’s net income for the year?

For the full year, GemPharmatech reported net income of 144,40.

How much net income did GemPharmatech post in the last quarter?

In the most recent quarter, GemPharmatech (688046) posted net income of 34.50.

What was GemPharmatech’s gross profit for the year?

Gross profit for the year was reported at 793,25.

How much gross profit did GemPharmatech generate last quarter?

GemPharmatech recorded gross profit of 424,79 in its latest quarterly report.

What was GemPharmatech’s annual operating income?

For the full year, GemPharmatech (688046) reported operating income of 164,55.

What was GemPharmatech’s operating income last quarter?

Quarterly operating income was 51,26.

What was GemPharmatech’s quarterly EBITDA?

In the latest quarter, EBITDA was reported at 69,46.

What was the quarter-over-quarter change in EBITDA for GemPharmatech?

EBITDA changed by 23,30% compared to the last quarter.

What is GemPharmatech’s most recent gross profit margin?

The latest reported gross profit margin for GemPharmatech (688046) is 195,15%.

What is GemPharmatech’s most recent net income margin?

Net income margin based on recent financials is 15,85%.

What is GemPharmatech’s most recent EBIT margin?

GemPharmatech reported an EBIT margin of 23,55% based on current figures.

How did GemPharmatech’s revenue change compared to the previous quarter?

Revenue changed by 8,42% compared to the prior quarter.

What was the quarter-over-quarter change in gross profit for GemPharmatech?

In the latest quarter 2026, gross profit changed by 233,87% from the previous quarter.

South Africa Top 40

110,515.90

-2,271.44

-2.01%

S. Africa 40 Futures

107,047.00

+350

+0.33%

US 30

48,942.20

-558.7

-1.13%

US 500

6,803.30

-79.4

-1.15%

US Tech 100

24,554.20

-337.0

-1.35%

DAX Futures

24,566.50

-177.5

-0.72%

Dollar Index

97.72

+0.231

+0.24%

Market Movers

Name	Last	Chg. %	Vol.
MTN	17 596	-5,76%	7,37M
Impala Platinum	28 154	-9,16%	4,69M
Northam Platinum Holdings	35 612,00	-9,28%	2,62M
Naspers	94 166	+0,52%	2,32M
Gold Fields	82 732	-3,08%	1,83M
Valterra Platinum	140 978	-5,07%	1,74M
AngloGold Ashanti ADR	159 961	-3,58%	871,20K

Name	Last	Chg. %	Vol.
Numeral	30	+50,00%	20,70K
Marshall Monteagle PLC	3 100	+10,71%	496,00
Quantum Foods Holdings	1 050	+10,53%	28,09K
RH Bophelo	186	+8,77%	15,00K
Montauk Renewables	2 800,00	+6,79%	9,90K
Accelerate Property Fund Ltd	70	+6,06%	405,95K
Eastern Platinum	801	+5,39%	3,74K

Name	Last	Chg. %	Vol.
Oando Plc	19	-38,71%	200,00
Labat Africa Ltd	6	-14,29%	31,94M
ASP Isotopes	9 088,00	-13,83%	157,53K
Mtn Zakhele Futhi	18,00	-10,00%	2,69K
Northam Platinum Holdings	35 612,00	-9,28%	2,62M
Capitec Bank Pref	10 252	-9,27%	104,00
Impala Platinum	28 154	-9,16%	4,69M

Trending Stocks

Name	Last	Chg. %	Vol.
Sasol	11 035	-3,83%	4,70M
Sibanye Stillwater	6 490	-8,40%	14,13M
Naspers	94 166	+0,52%	2,32M
Impala Platinum	28 154	-9,16%	4,69M
Gold Fields	82 732	-3,08%	1,83M

Most Undervalued Stocks

Name	Last	Upside	Fair Value
Aaaaaaaa Aaaaaaaaaaa	11,035	+49.94%	16 546
Aaaaaaaaaaaaaaaaa	1,567	+47.54%	2 312
A Aaaaaaaaa	15,900	+45.76%	23 176
A Aaaaaaaaaaa Aaa	3,850	+41.22%	5 437
Aaaaaaaa	5,438	+40.74%	7 653
Aaaaaaaaa	5,590	+40.07%	7 830
Aaa Aaaaaa Aaaaa	16,979	+36.97%	23 256

Name	Last	Upside	Fair Value
Aaaaaaaa Aaaaaaaaaaa	11,035	+49.94%	16 546
Aaaaaaaaaaaaaaaaa	1,567	+47.54%	2 312
A Aaaaaaaaa	15,900	+45.76%	23 176
A Aaaaaaaaaaa Aaa	3,850	+41.22%	5 437
Aaaaaaaa	5,438	+40.74%	7 653
Aaaaaaaaa	5,590	+40.07%	7 830
Aaa Aaaaaa Aaaaa	16,979	+36.97%	23 256

See full list

Install Our AppScan QR code to install app

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

Popular Searches

Please try another search

GemPharmatech Co Ltd (688046)

688046 Income Statement

FAQ

What was GemPharmatech’s revenue at year end?

How much revenue did GemPharmatech report in the most recent quarter?

What was GemPharmatech’s net income for the year?

How much net income did GemPharmatech post in the last quarter?

What was GemPharmatech’s gross profit for the year?

How much gross profit did GemPharmatech generate last quarter?

What was GemPharmatech’s annual operating income?

What was GemPharmatech’s operating income last quarter?

What was GemPharmatech’s quarterly EBITDA?

What was the quarter-over-quarter change in EBITDA for GemPharmatech?

What is GemPharmatech’s most recent gross profit margin?

What is GemPharmatech’s most recent net income margin?

What is GemPharmatech’s most recent EBIT margin?

How did GemPharmatech’s revenue change compared to the previous quarter?

What was the quarter-over-quarter change in gross profit for GemPharmatech?

Trending Stocks